EBX-102-02
Phase 2- Indications
- Irritable bowel syndrome with constipation (IBS-C), Irritable bowel syndrome with diarrhea (IBS-D)
Company intelligence / Profile preview
Environmental consulting firm specializing in biological assessments and regulatory compliance, led by Alan Darlington in Guelph, Ontario
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Darlington Biological Consulting.